Cerebrovascular Diseases

Papers
(The H4-Index of Cerebrovascular Diseases is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Intensive Blood Pressure Lowering and Renal Function in Ischemic Stroke Patients: Secondary Analysis of the ENCHANTED Trial45
Retraction Statement26
Impact of RNF213 c.14576G>A Variant on the Development of Direct and Indirect Revascularization in Pediatric Moyamoya Disease26
Normobaric Hyperoxia Combined with Endovascular Treatment in Patients with Acute Ischemic Stroke (OPENS-2) Trial: Protocol for a Prospective, Multicenter, Randomized Controlled Study22
Circulating Biomarkers Predict Symptomatic but Not Asymptomatic Carotid Artery Stenosis20
Factors Associated with Discharge against Medical Advice among Acute Stroke Patients: Analysis of the Nationwide Emergency Department Sample20
Circadian Rhythm Disturbance in Acute Ischemic Stroke Patients and Its Effect on Prognosis19
Treatment Strategies and Prognosis for Moderate Stroke Patients in China17
Sex-Based Differences in the Outcomes of Intracerebral Haemorrhage: A Systematic Review and Meta-Analysis16
Meta-Analysis of Functional Electrical Stimulation Combined with Occupational Therapy on Post-Stroke Limb Functional Recovery and Quality of Life16
Rich-Club Analysis of the Structural Brain Network in Cases with Cerebral Small Vessel Disease and Depression Symptoms15
Asia Pacific Stroke Conference 2024 Combined Australian and New Zealand Stroke Organisation Conference15
Endovascular Treatment for Cerebral Venous Thrombosis: Applying Lessons Learned from Clinical Trials of Endovascular Treatment in Acute Arterial Ischemic Stroke15
LOXL2 Inhibitor Attenuates Angiotensin II-Induced Atrial Fibrosis and Vulnerability to Atrial Fibrillation through Inhibition of Transforming Growth Factor Beta-1 Smad2/3 Pathway15
0.31088805198669